Proliferative vitreoretinopathy-developments in adjunctive treatment and retinal pathology
- PMID: 12101443
- DOI: 10.1038/sj.eye.6700194
Proliferative vitreoretinopathy-developments in adjunctive treatment and retinal pathology
Abstract
Proliferative vitreoretinopathy (PVR) remains a difficult management problem despite advances in vitreoretinal surgery. There is still a significant incidence of PVR in rhegmatogenous retinal detachment and other forms of retinal disease. Surgery for PVR now has a high anatomical success rate although visual results are often disappointing. The use of adjunctive treatments to prevent cellular proliferation holds promise for the prevention of PVR or recurrences after surgery. Control of proliferation and strategies aimed at improving visual outcome are important areas of future research in PVR and other forms of retinal disease. Studies of the intraretinal and peri-retinal pathology of PVR have demonstrated characteristic changes which may have a significant influence on visual outcome and surgical management.
Similar articles
-
Prevalence and risk factors for proliferative vitreoretinopathy in eyes with rhegmatogenous retinal detachment but no previous vitreoretinal surgery.Am J Ophthalmol. 2004 Jun;137(6):1105-15. doi: 10.1016/j.ajo.2004.02.008. Am J Ophthalmol. 2004. PMID: 15183797
-
Outcomes of vitrectomy with inferior retinectomy in patients with recurrent rhegmatogenous retinal detachments and proliferative vitreoretinopathy.Ophthalmology. 2006 Nov;113(11):2041-7. doi: 10.1016/j.ophtha.2006.05.039. Epub 2006 Sep 6. Ophthalmology. 2006. PMID: 16952397
-
[Proliferative vitreoretinopathy--pathogenesis and therapy].Klin Monbl Augenheilkd. 2010 Mar;227(3):168-74. doi: 10.1055/s-0029-1245300. Epub 2010 Mar 16. Klin Monbl Augenheilkd. 2010. PMID: 20234978 Review. German.
-
Prevention and control of proliferative vitreoretinopathy: primary retinal detachment surgery using silicone oil as a planned two-stage procedure in high-risk cases.Eye (Lond). 2008 Jun;22(6):815-8. doi: 10.1038/sj.eye.6702719. Epub 2007 Feb 2. Eye (Lond). 2008. PMID: 17277751
-
Proliferative vitreoretinopathy: developments in pathogenesis and treatment.Compr Ophthalmol Update. 2006 Jul-Aug;7(4):179-85. Compr Ophthalmol Update. 2006. PMID: 17007731 Review.
Cited by
-
Inhibitory effects of resveratrol on PDGF-BB-induced retinal pigment epithelial cell migration via PDGFRβ, PI3K/Akt and MAPK pathways.PLoS One. 2013;8(2):e56819. doi: 10.1371/journal.pone.0056819. Epub 2013 Feb 14. PLoS One. 2013. PMID: 23457620 Free PMC article.
-
Perfluoro-n-octane as a temporary intraocular tamponade in a staged approach to manage complex retinal detachments.Clin Ophthalmol. 2015 Feb 27;9:413-8. doi: 10.2147/OPTH.S76947. eCollection 2015. Clin Ophthalmol. 2015. PMID: 25784785 Free PMC article.
-
An ocular view of the IGF-IGFBP system.Growth Horm IGF Res. 2013 Jun;23(3):45-52. doi: 10.1016/j.ghir.2013.03.001. Epub 2013 Apr 8. Growth Horm IGF Res. 2013. PMID: 23578754 Free PMC article. Review.
-
Advances in Vitreoretinal Surgery.J Clin Med. 2022 Oct 30;11(21):6428. doi: 10.3390/jcm11216428. J Clin Med. 2022. PMID: 36362657 Free PMC article. Review.
-
Interaction of monocarboxylate transporter 4 with beta1-integrin and its role in cell migration.Am J Physiol Cell Physiol. 2009 Mar;296(3):C414-21. doi: 10.1152/ajpcell.00430.2008. Epub 2008 Dec 10. Am J Physiol Cell Physiol. 2009. PMID: 19073896 Free PMC article.
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials